Monthly Archives: August 2015

Yes, CFSAC, there is a FACA violation

Posted on August 31, 2015 by Jeannette Burmeister

“Yes, Virginia, there is a Santa Claus.”–From an 1897 editorial, “Is there a Santa Claus?” of The New York Sun I was contacted by a member of the Chronic Fatigue Syndrome Advisory Committee (CFSAC) regarding my blog post, “Oops, they did … Continue reading →

Posted in Uncategorized | Tagged Barbara James, CFS, CFSAC, Chronic Fatigue Syndrome, Chronic Fatigue Syndrome Advisory Committee, Designated, Designated Federal Officer, DFO, FACA violation, Federal Advisory Committee Act, FOIA, HHS, ME, ME/CFS, Myalgic Encephalomyelitis, Sections 5(b)(3) and (c) of FACA, Yes Virginia there is a Santa Claus | 19 Comments

Another CFSAC FACA Fail: DFO Misconstrues Law

Posted on August 20, 2015 by Jeannette Burmeister

On Monday, I published a post about CFSAC violating the Federal Advisory Committee Act (“FACA”) by failing to make the the working group’s draft P2P comments available to the public prior to, or at the time of, the January 2015 CFSAC meeting. … Continue reading →

Posted in Uncategorized | Tagged August 2015 Meeting, Barbara James, CFS, CFSAC, Chronic Fatigue Syndrome, Chronic Fatigue Syndrome Advisory Committee, Dr. Nancy Lee, FACA, FACA violation, Federal Advisory Committee Act, FOIA Exemption, ME, ME/CFS, Myalgic | 26 Comments

Oops, they did it again! CFSAC violates FACA

Posted on August 18, 2015 by Jeannette Burmeister

This is a post about the violation of federal law by CFSAC yet again. This is also a post about how HHS has controlled CFSAC’s input on the P2P report. CFSAC violated FACA, the Federal Advisory Committee Act, again. Not … Continue reading →

Posted in Uncategorized | Tagged Barbara James, CFS, CFSAC, CFSAC Working Group, Chronic Fatigue Syndrome, Chronic Fatigue Syndrome Advisory Committee, DFO, Dr. Fletcher, FACA, FACA violation, Federal Advisory Committee Act, HHS, ME, ME/CFS, Myalgic Encephalomyelitis, P2P, Pathways for Prevention | 23 Comments

CFSAC Comments August 2015: Ampligen Price Increase on Shaky Ground

Posted on August 14, 2015 by Jeannette Burmeister

I looked into the Ampligen issue–the exorbitant 267% price increase by Hemispherx–some more. Here is one thing that patients who are currently enrolled in the trial can do. They can contact Schulman Associates, the Institutional Review Board (IRB) for this … Continue reading →

Posted in Uncategorized | Tagged Ampligen, CFS, CFSAC, Chronic Fatigue Syndrome, Chronic Fatigue Syndrome Advisory Committee, Cost recovery, Dr. Woodcock, FDA, Hemispherx, ME, ME/CFS, Myalgic Encephalomyelitis, Open-label trial, Price Increase | 42 Comments

267% Price Increase for Ampligen

Posted on August 12, 2015 by Jeannette Burmeister

[Please see here for my follow-up letter to Dr. Woodcock.] I just sent the following message regarding Hemispherx’s extraordinary 267% price increase for Ampligen to Dr. Janet Woodcock, the FDA’s Director of the Center for Drug Evaluation and Research: Dear Dr. … Continue reading →

Posted in Uncategorized | Tagged Ampligen, CFS, Chronic Fatigue Syndrome, Dr. Woodcock, FDA, HEB, Hemispherx, ME, ME/CFS, Myalgic Encephalomyelitis, Price Increase | 31 Comments

Monthly Archives: August 2015

Yes, CFSAC, there is a FACA violation

Another CFSAC FACA Fail: DFO Misconstrues Law

Oops, they did it again! CFSAC violates FACA

CFSAC Comments August 2015: Ampligen Price Increase on Shaky Ground

267% Price Increase for Ampligen

Follow Blog via Email

Recent Posts

Archives

Blogs

Disability Resources

Forums

Severe M.E.

Support Groups

Websites

Legal Disclaimer